{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:20:59Z","timestamp":1790191259595,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.vaccine.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T07:22:23Z","timestamp":1647069743000},"page":"2266-2273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Real-world evidence on adherence and completion of the two-dose recombinant zoster vaccine and associated factors in U.S. adults, 2017\u20132021"],"prefix":"10.1016","volume":"40","author":[{"given":"Joyce","family":"LaMori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Pericone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mesa-Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obiageli","family":"Sogbetun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Kulczycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.03.006_b0005","unstructured":"Centers for Disease Control and Prevention. Shingles Burden and Trends, https:\/\/www.cdc.gov\/shingles\/surveillance.html;2019 [accessed 28 January 2022]."},{"issue":"9","key":"10.1016\/j.vaccine.2022.03.006_b0010","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","article-title":"Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.006_b0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12877-017-0420-9","article-title":"The temporal impact of aging on the burden of herpes zoster","volume":"17","author":"Varghese","year":"2017","journal-title":"BMC Geriatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.006_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.006_b0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cid\/ciab121","article-title":"Effectiveness of the recombinant zoster vaccine in adults aged 50 and older in the United States: a claims-based cohort study","volume":"73","author":"Sun","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.006_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations -United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.006_b0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.vaccine.2020.12.076","article-title":"Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older","volume":"39","author":"Ackerson","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.006_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/21645515.2018.1512453","article-title":"Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature","volume":"15","author":"Hirth","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2022.03.006_b0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.amepre.2021.04.031","article-title":"Factors associated with human papillomavirus vaccine series completion among adolescents","volume":"61","author":"Mansfield","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2022.03.006_b0050","doi-asserted-by":"crossref","unstructured":"Patterson BJ, Chen CC, McGuiness CB, Glasser LI, Sun K, Buck PO. Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019. Hum Vaccin Immunother. 2021:1-6","DOI":"10.1080\/21645515.2021.1879579"},{"key":"10.1016\/j.vaccine.2022.03.006_b0055","unstructured":"MEDICARE PART D VACCINES, cms.gov\/outreach-and-education\/medicare-learning-network-mln\/mlnproducts\/downloads\/vaccines-part-d-factsheet-icn908764.pdf; 2021 [accessed 28 January 2022]."},{"key":"10.1016\/j.vaccine.2022.03.006_b0060","unstructured":"Optum. Real world health care experiences, https:\/\/www.optum.com\/content\/dam\/optum\/resources\/productSheets\/5302_Data_Assets_Chart_Sheet_ISPOR.pdf; 2015 [accessed 28 January 2022]."},{"issue":"2","key":"10.1016\/j.vaccine.2022.03.006_b0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1467-8306.1971.tb00779.x","article-title":"Error on choroplethic maps: definition, measurement, reduction","volume":"61","author":"Jenks","year":"1971","journal-title":"Ann Assoc Am Geogr"},{"issue":"7","key":"10.1016\/j.vaccine.2022.03.006_b0070","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/21645515.2020.1856598","article-title":"The role of social determinants in timely herpes zoster vaccination among older American adults","volume":"17","author":"Shuvo","year":"2021","journal-title":"Human Vaccines Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2022.03.006_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.15585\/mmwr.mm7007a4","article-title":"Decline in receipt of vaccines by medicare beneficiaries during the COVID-19 pandemic - United States, 2020","volume":"70","author":"Hong","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.03.006_b0080","unstructured":"Hamza Z. Shingrix OK'd for Immunocompromised Adults, https:\/\/www.medpagetoday.com\/infectiousdisease\/generalinfectiousdisease\/93760; 2021 [accessed 28 January 2022]."},{"key":"10.1016\/j.vaccine.2022.03.006_b0085","unstructured":"American Pharmacist Association. Pharmacist Administered Vaccines, https:\/\/media.pharmacist.com\/practice\/IZ_Authority_012019_corrected_April_2019.pdf; 2019 [accessed 28 January 2022]."},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.006_b0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.amepre.2018.05.011","article-title":"Clinicians' and pharmacists' reported implementation of vaccination practices for adults","volume":"55","author":"Lutz","year":"2018","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.006_b0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1331\/JAPhA.2013.12019","article-title":"Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies","volume":"53","author":"Wang","year":"2013","journal-title":"J Am Pharm Assoc: JAPhA"},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.006_b0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/21645515.2019.1637218","article-title":"The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster","volume":"16","author":"Tak","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2022.03.006_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations - United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"10.1016\/j.vaccine.2022.03.006_b0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.amepre.2021.03.023","article-title":"Racial\/ethnic and socioeconomic disparities in adult vaccination coverage","volume":"61","author":"Kawai","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2022.03.006_b0115","unstructured":"Cubanski J, Neuman J, Damico S. Who Didn\u2019t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines, https:\/\/www.kff.org\/medicare\/issue-brief\/who-didnt-get-a-second-shingrix-shot-implications-for-multidose-covid-19-vaccines\/; 2020 [accessed 28 January 2022]."},{"key":"10.1016\/j.vaccine.2022.03.006_b0120","first-page":"1","article-title":"Shingles vaccination among adults aged 60 and over: United States","volume":"2020","author":"Terlizzi","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.006_b0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s41669-021-00262-x","article-title":"State-level variations and factors associated with adult vaccination coverage: a multilevel modeling approach","volume":"5","author":"Garbinsky","year":"2021","journal-title":"Pharmacoecon Open"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.006_b0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1525-1446.2011.00958.x","article-title":"Racial and ethnic disparities in human papillomavirus awareness and vaccination among young adult women","volume":"28","author":"Ford","year":"2011","journal-title":"Public Health Nurs"},{"key":"10.1016\/j.vaccine.2022.03.006_b0135","doi-asserted-by":"crossref","unstructured":"Elekwachi O, Wingate LMT, Clarke Tasker V, Aboagye L, Dubale T, Betru D, et al. A Review of Racial and Ethnic Disparities in Immunizations for Elderly Adults. Journal of Primary Care & Community Health. 2021;12:21501327211014071","DOI":"10.1177\/21501327211014071"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.006_b0140","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.amepre.2015.03.005","article-title":"Racial and ethnic disparities in vaccination coverage among adult populations in the U.S","volume":"49","author":"Lu","year":"2015","journal-title":"Am J Prev Med"},{"issue":"43","key":"10.1016\/j.vaccine.2022.03.006_b0145","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.vaccine.2014.08.040","article-title":"Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies","volume":"32","author":"Teeter","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.006_b0150","unstructured":"Centers for Disease Control and Prevention. Noninfluenza vaccination coverage among adults - United States, 2011. MMWR Morb Mortal Wkly Rep. 2013;62:66-72."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:46Z","timestamp":1759403506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22002687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":30,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0264410X22002687"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world evidence on adherence and completion of the two-dose recombinant zoster vaccine and associated factors in U.S. adults, 2017\u20132021","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}